All In Biotech

Drug Trial Radar · NCT07593885

A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Apr 30, 2026

Primary completion

Nov 2026

Study completion Nov 2026

Sponsor

Sponsor type
Industry
First posted
May 18, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Double-Masked, Randomized, Parallel Group, Non-Inferiority Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease

Conditions

  • Dry Eye

Interventions

  • Artelac® Complete MDO® Eye DropsDrug

    Self-administered eye drops

  • VISMED® MULTI Eye DropsDrug

    Self-administered eye drops

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary performance endpoint for this study is change from baseline (CFB) at Visit 3 (Day 90) in total OSDI score.Time frame: Assessed at Visit 3 (Day 90)

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Klinik für Augenheilkunde, Universitätklinikum Freiburg

    Freiburg im Breisgau, Baden-Wurttemberg, Germany · Recruiting

  • Universitäts-Augenklinik Heidelberg

    Heidelberg, Baden-Wurttemberg, Germany · Recruiting

  • Universitätsklinikum Tübingen, Department für Augenheilkunde

    Tübingen, Baden-Wurttemberg, Germany · Recruiting

  • Department of Ophthalmology, Ludwig Maximilian University

    Munich, Bavaria, Germany · Recruiting

  • Augen & Haut Zentrum-Praxis Dr. Jacobi

    Nuremberg, Bavaria, Germany · Recruiting

  • Chiemsee Augentagesklinik, Prien

    Prien am Chiemsee, Bavaria, Germany · Recruiting

  • Augen-Zentrum-Nordwest

    Ahaus, North Rhine-Westphalia, Germany · Recruiting

  • Medizinisches Versorungszentrum AR Augenblick Rheinland GmbH

    Brühl, North Rhine-Westphalia, Germany · Not yet recruiting

  • University Eye Clinic Cologne

    Cologne, North Rhine-Westphalia, Germany · Not yet recruiting

  • Klinik für Augenheilkunde / Universitätsklinikum Düsseldorf

    Düsseldorf, North Rhine-Westphalia, Germany · Not yet recruiting

  • Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz

    Mainz, Rhineland-Palatinate, Germany · Recruiting

  • University Saarland Medical Center

    Homburg, Saarland, Germany · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.